Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • Log out
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Binding of Drugs to Human Serum Albumin:

XI. The Specificity of Three Binding Sites as Studied with Albumin Immobilized in Microparticles

INGVAR SJÖHOLM, BO EKMAN, ANITA KOBER, INGRID LJUNGSTEDT-PÅHLMAN, BIRGITTA SEIVING and TORGNY SJÖDIN
Molecular Pharmacology November 1979, 16 (3) 767-777;
INGVAR SJÖHOLM
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BO EKMAN
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANITA KOBER
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INGRID LJUNGSTEDT-PÅHLMAN
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BIRGITTA SEIVING
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TORGNY SJÖDIN
Department of Pharmaceutical Biochemistry, Biomedical Center, University of Uppsala, Box 578, S-751 23 Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

This article has a correction. Please see:

  • Binding of Drugs to Human Serum Albumin: - July 01, 1980

Abstract

Human serum albumin can be immobilized in spherical, macroporous microparticles of polyacrylamide of about 1 µm in diameter with retention of its native properties. It has been shown that diazepam, digitoxin and warfarin independently bind to albumin and can conveniently be used as markers of three separate, discrete binding sites on albumin. A simple technique has been devised by which the capacity of about 140 drugs and other compounds to affect the binding of the radioactively labeled markers has been studied. Some drugs, e.g. antirheumatic drugs of the isopropionic acid-type, some antidiabetic agents, penicillin derivatives, benzodiazepines, tryptophan, dansylsarcosine, and suiphobromophthalein efficiently displace diazepam. Other drugs, e.g., some diuretics, sulpha drugs, phenytoin, salicylic acid and butazone derivatives, azapropazoe, bilirubin, and dansylamide displace warfarin. Displacement of digitoxin is less common. In some cases the binding of the markers is improved, e.g., tamoxifen increases the binding of warfarin. Both competitive and allosteric mechanisms are responsible for the changed binding of the markers. Some results suggest the presence of more than the three binding sites for drugs on the albumin surface studied with diazepam, digitoxin and warfarin.

ACKNOWLEDGMENTS The skillful technical assistance from Mr. Börje Berg, Miss Solveigh Höglund, Mrs. Elisabeth Tidare and Mrs. Linnéa Wallsten is gratefully acknowledged. We also thank the manufacturers and their Swedish representatives for supplying us with the drugs used.

  • Copyright © 1979 by Academic Press, Inc.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 16, Issue 3
1 Nov 1979
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Binding of Drugs to Human Serum Albumin:
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Binding of Drugs to Human Serum Albumin:

INGVAR SJÖHOLM, BO EKMAN, ANITA KOBER, INGRID LJUNGSTEDT-PÅHLMAN, BIRGITTA SEIVING and TORGNY SJÖDIN
Molecular Pharmacology November 1, 1979, 16 (3) 767-777;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Binding of Drugs to Human Serum Albumin:

INGVAR SJÖHOLM, BO EKMAN, ANITA KOBER, INGRID LJUNGSTEDT-PÅHLMAN, BIRGITTA SEIVING and TORGNY SJÖDIN
Molecular Pharmacology November 1, 1979, 16 (3) 767-777;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Articles

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics